Table 2. HGV RNA in Serum of Patients... | American Society of Hematology

Table 2.

HGV RNA in Serum of Patients With Non–A-E FH

Patient Source	Serum HGV RNA (+)	Patients With Transfusion^*
Northeast (n = 5)	1 (20)	0 (0)
Mid-Atlantic (n = 22)	12 (55)	17 (77)
Southeast (n = 9)	1 (11)	0 (0)

FH with known etiology (n = 10)^†	2 (20)	3 (30)
Healthy controls (n = 10)	1 (10)	0 (0)

Patient Source	Serum HGV RNA (+)	Patients With Transfusion^*
Northeast (n = 5)	1 (20)	0 (0)
Mid-Atlantic (n = 22)	12 (55)	17 (77)
Southeast (n = 9)	1 (11)	0 (0)

FH with known etiology (n = 10)^†	2 (20)	3 (30)
Healthy controls (n = 10)	1 (10)	0 (0)

Values are the numbers of patients with percentages in parentheses.

Patients with non–A-E FH with a history of transfusion of plasma or exchange plasmapheresis.

Eight therapeutic drug-induced FH: 6 acetaminophen, 1 isoniazide, and 1 progabide. Two Wilson’s FH.